Some authors have pointed out that the early use of lipophilic statins is associated with a significant decrease in the progression of AD in those with mild-moderate AD, and its use could be beneficial in patients with AD since it modifies cognitive deterioration mainly in those subjects homozygous for ApoE4 [222,223]. The gene discussed is APOE; the disease is Alzheimer disease.